MEREO BIOPHARMA GROUP PLC shareholders Q3 2023

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 57 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

MEREO BIOPHARMA GROUP PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Tejara Capital Ltd 3,215,001$4,147,3512.35%
Soleus Capital Management, L.P. 9,677,419$12,483,8711.15%
683 Capital Management, LLC 6,000,000$7,740,0000.60%
Rubric Capital Management LP 11,616,120$14,984,7950.56%
MANGROVE PARTNERS IM, LLC 5,531,547$7,135,6960.54%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,364,438$9,500,1250.51%
DAFNA Capital Management LLC 962,513$1,241,6420.39%
Clearline Capital LP 3,102,723$4,002,5120.34%
Rock Springs Capital Management LP 7,676,481$9,902,6600.26%
Monaco Asset Management SAM 595,729$768,4900.23%
Formidable Asset Management, LLC 331,914$428,1690.10%
Forefront Analytics, LLC 65,649$84,6900.05%
Privium Fund Management (UK) Ltd 24,726$32,3910.02%
Ikarian Capital, LLC 591,676$191,2810.02%
J. Goldman & Co LP 445,485$574,6760.02%
Tidal Investments LLC 331,914$428,1690.01%
Clear Harbor Asset Management, LLC 63,754$82,2430.01%
Alkeon Capital Management 3,738,100$4,822,1490.01%
PFG Investments, LLC 30,000$38,7000.01%
NEOS Investment Management LLC 41,328$53,3130.01%
External links

This page lists MEREO BIOPHARMA GROUP PLC's shareholders in Q3 2023. To view MEREO BIOPHARMA GROUP PLC's shareholder history, click here.